A Phase II/III, multicenter, partially randomized, open

Project: Research project

Description

A Phase II/III, multicenter, partially randomized, open label trial investigating safety and efficacy of ondemand and prophylactic treatment with BAY 94-9027 in severe hemophilia A
StatusFinished
Effective start/end date4/24/1212/31/18

Funding

  • BAYER HEALTHCARE PHARMACEUTICALS

Fingerprint

Hemophilia A
Safety
BAY 94-9027